Zobrazeno 1 - 10
of 1 052
pro vyhledávání: '"botulinum-A toxin"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-15 (2024)
Abstract The bacterium Clostridium botulinum, well-known for producing botulinum neurotoxins, which cause the severe paralytic illness known as botulism, produces C2 toxin, a binary AB-toxin with ADP-ribosyltranferase activity. C2 toxin possesses two
Externí odkaz:
https://doaj.org/article/638fda21750d43c9b0f8a3f05ef59eb4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Botulinum neurotoxin type A (BoNT-A) is a first-line treatment option for post-stroke spasticity, reducing pain and involuntary movements and helping to restore function. BoNT-A is frequently injected into the arm, wrist, hand and/or finger muscles,
Externí odkaz:
https://doaj.org/article/ffeba5c71fd142ffaeffa4fd6e8900b8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Di-san junyi daxue xuebao, Vol 43, Iss 17, Pp 1684-1688 (2021)
Objective To explore the diagnostic criteria of botulism after botulinum toxin type A (BT/A) injection and observe the therapeutic effect of botulinum antitoxin. Methods From August 2018 to June 2020, 9 patients suffering from botulism after BT/A inj
Externí odkaz:
https://doaj.org/article/1043a48510f9439b8519a8204e207833
Autor:
Sebastian Heber, Joscha Borho, Nicole Stadler, Fanny Wondany, Irina König, Jens Michaelis, Panagiotis Papatheodorou, Holger Barth, Maximilian Fellermann
Publikováno v:
Toxins, Vol 15, Iss 6, p 390 (2023)
The binary Clostridium (C.) botulinum C2 toxin consists of two non-linked proteins. The proteolytically activated binding/transport subunit C2IIa forms barrel-shaped homoheptamers, which bind to cell surface receptors, mediate endocytosis, and transl
Externí odkaz:
https://doaj.org/article/66b5f7fb68b34416971626e785278fd1
Autor:
COSMAN CAMILO MANDUJANO, DIEGO LAURENTINO LIMA, ANALENA ALCABES, PATRICIA FRIEDMANN, XAVIER PEREIRA, FLAVIO MALCHER
Publikováno v:
Revista do Colégio Brasileiro de Cirurgiões, Vol 49 (2022)
ABSTRACT Introduction: the botulinum toxin A (BTA) has been used to achieve a chemical component separation, and it has been used with favorable outcomes for the repair of complex ventral hernia (CVH) with and without loss of domain (LD). The aim of
Externí odkaz:
https://doaj.org/article/56141e566ae74947a3674a05be72986f
Autor:
Bin Shen, Lan Wang
Publikováno v:
Journal of Integrative Neuroscience, Vol 19, Iss 1, Pp 201-208 (2020)
A systematic review of the impact of botulinum-A toxin as a therapeutic regimen for the management of adult migraine disorders is shown to that Botulinum-A toxin provides a more significant reduction in the number of headache episodes per month relat
Externí odkaz:
https://doaj.org/article/b876eba9dd6e40afa6449da1bfc9f86b
Autor:
Laura M. Scorr, Stewart A. Factor, Sahyli Perez Parra, Rachel Kaye, Randal C. Paniello, Scott A. Norris, Joel S. Perlmutter, Tobias Bäumer, Tatiana Usnich, Brian D. Berman, Marie Mailly, Emmanuel Roze, Marie Vidailhet, Joseph Jankovic, Mark S. LeDoux, Richard Barbano, Florence C. F. Chang, Victor S. C. Fung, Sarah Pirio Richardson, Andrew Blitzer, H. A. Jinnah
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Objective: The goal of this study is to better characterize the phenotypic heterogeneity of oromandibular dystonia (OMD) for the purpose of facilitating early diagnosis.Methods: First, we provide a comprehensive summary of the literature encompassing
Externí odkaz:
https://doaj.org/article/0634a2ad37b94f16a06e33a9b223c951
Autor:
Raveen Syan, Mason A. Briggs, John C. Olivas, Sakti Srivastava, Craig V. Comiter, Amy D. Dobberfuhl
Publikováno v:
Investigative and Clinical Urology, Vol 60, Iss 1, Pp 40-45 (2019)
Purpose: OnabotulinumtoxinA (BTX) detrusor chemodenervation is an efficacious third-line treatment for overactive bladder. Despite high clinical efficacy rates for BTX injection, many patients refuse initial or repeat treatment due to the invasivenes
Externí odkaz:
https://doaj.org/article/ebf093d7c02d46fbb785ac7ad71ebe8c